Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?

Background: Yellow fever vaccine (YFV) is not advised for multiple sclerosis (MS) patients because of the potential risk of post-vaccine relapses. Objective: To assess the risk of relapsing-remitting multiple sclerosis (RR-MS) worsening after YFV. Methods: Non-interventional observational retrospect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	MULTIPLE SCLEROSIS JOURNAL 2021-12, Vol.27 (14), p.2280-2283
Hauptverfasser:	Papeix, Caroline, Mazoyer, Julie, Maillart, Elisabeth, Bensa, Caroline, Dubessy, Anne-Laure, Goujon, Catherine, Launay, Odile, Lebrun-Frénay, Christine, Louapre, Céline, Mrejen, Serge, Pourcher, Valérie, Rosenheim, Michel, Stankoff, Bruno, Vidal, Jean-Sebastien, Lubetzki, Catherine
Format:	Artikel
Sprache:	eng
Schlagworte:	Cohort Studies Human health and pathology Humans Interferon Life Sciences Multiple sclerosis Multiple Sclerosis - epidemiology Multiple Sclerosis, Relapsing-Remitting - epidemiology Retrospective Studies Vaccination Vaccination - adverse effects Vaccines Yellow fever Yellow Fever - epidemiology Yellow Fever - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!